Bioengineered Protein Drug Market Segmentation:
Drug Type Segment Analysis
The global bioengineered protein drug market is segmented and analyzed for demand and supply by drug type into recombinant protein, vaccine, peptide antibiotics, therapeutic enzymes, and others. Out of these types of drugs, the therapeutic enzymes segment is estimated to gain the largest market share in the year 2035. The growth of the segment can be attributed to the extensive use of therapeutic enzymes in the manufacturing of therapeutic proteins and the processing of recombinant DNA. Macromolecular therapeutic proteins, such as interferons, cytokines, and monoclonal antibodies, are extensively used in the treatment of HIV, cancer, and other diseases. A higher prevalence of HIV and cancer can be observed among the global population owing to several reasons such as rising tobacco and alcohol consumption, and others. For instance, it was estimated that nearly 8 million people lose their lives on account of tobacco consumption every year. Additionally, approximately 80% of tobacco users are observed to be living in developing countries.
Application Segment Analysis
The global bioengineered protein drug market is also segmented and analyzed for demand and supply by application into autoimmune, heart, congenital, infectious diseases, cancer, diabetes, arthritis, and others. Amongst these segments, the cancer segment is expected to garner a significant share in the year 2035. Cancer is the most common cause of mortality worldwide. Several types of antibodies are used to cure cancer such as monoclonal antibodies. These antibodies are cured in the labs to attack specific targets on cancer cells. Bioengineering cancer therapies include re-engineering tumor microenvironments to eliminate tumor-promoting cues and developing next-generation cell-based therapies. Furthermore, it was also observed in multiple studies that cancer patients require more protein than an ordinary healthy person. Since tumor kills the cell while bioengineered protein helps the tissues to fight infections. Some instances of the most suitable drugs for cancer are 5-fluorouracil, methotrexate, 6-mercaptopurine, gemcitabine, and cytarabine.
Our in-depth analysis of the global market includes the following segments:
|
By Drug Type |
|
|
By Application |
|
|
By Technology |
|
|
By Drug Delivery Method |
|
